In a recent research letter published in the journal Nature Aging, researchers used proteomic sequencing of patients' and controls' cerebrospinal fluids to investigate the heterogeneity of Alzheimer's ...
Proteins floating in the cerebrospinal fluid might do more than diagnose Alzheimer’s disease—they may identify different subtypes, according to researchers led by Betty Tijms of the Amsterdam ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback